VCG
Vantage Consulting Group’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-222
| Closed | -$233K | – | 143 |
|
|
2024
Q2 | $233K | Sell |
222
-22
| -9% | -$23.1K | 0.17% | 133 |
|
|
2024
Q1 | $235K | Sell |
244
-33
| -12% | -$31.8K | 0.15% | 152 |
|
|
2023
Q4 | $243K | Sell |
277
-5
| -2% | -$4.39K | 0.16% | 133 |
|
|
2023
Q3 | $232K | Sell |
282
-25
| -8% | -$20.6K | 0.16% | 140 |
|
|
2023
Q2 | $221K | Sell |
307
-13
| -4% | -$9.34K | 0.13% | 179 |
|
|
2023
Q1 | $263K | Hold |
320
| – | – | 0.15% | 128 |
|
|
2022
Q4 | $231K | Sell |
320
-39
| -11% | -$28.1K | 0.14% | 153 |
|
|
2022
Q3 | $247K | Sell |
359
-66
| -16% | -$45.4K | 0.14% | 120 |
|
|
2022
Q2 | $251K | Buy |
425
+66
| +18% | +$39K | 0.14% | 124 |
|
|
2022
Q1 | $251K | Sell |
359
-31
| -8% | -$21.7K | 0.1% | 135 |
|
|
2021
Q4 | $246K | Buy |
390
+15
| +4% | +$9.46K | 0.07% | 181 |
|
|
2021
Q3 | $227K | Sell |
375
-49
| -12% | -$29.7K | 0.05% | 170 |
|
|
2021
Q2 | $237K | Buy |
+424
| New | +$237K | 0.04% | 150 |
|
|
2021
Q1 | – | Sell |
-153
| Closed | -$74K | – | 1225 |
|
|
2020
Q4 | $74K | Buy |
+153
| New | +$74K | 0.01% | 288 |
|